|SEQ_NO||1||Date of announcement||2021/06/10||Time of announcement||17:33:38|
|Subject||Announcement of TTY Biopharm's unaudited income information in May 2021|
|Date of events||2021/06/10||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2021/06/10
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $378,770 thousands(expressed in NT dollars; unaudited), a consolidated operating loss of $117,073 thousands, and a consolidated loss before income tax of $100,158 thousands in May 2021; loss attributed to stockholders of the parent company was $123,069 thousands; EPS is $-0.49.
Year-to-date consolidated net sales was $1,696,549 thousands (in NT dollars; unaudited), a consolidated operating profit was $190,598 thousands and consolidated income before tax was $242,595 thousands until May 2021; year-to-date net income attributed to stockholders of the company was $150,577 thousands; EPS is $0.61.
7.Any other matters that need to be specified:
(1)The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.
(2)In May, 2021, the company recognized the penalty by Fair Trading Committee for NTD 220 million. Even the company will raise administrative relief to maintain shareholders' right, the penalty still impacted financial result for this month.